Invest now
Godavari Drugs share price
High risk
You have to be logged in to add this to Watchlist.- ₹115.20(-1.54%)October 7, 2026 10:01:42 AM IST
- NSE
- BSE
- Vol : 0.12 K (NSE + BSE)Last 20 day avg : 11.05 K
Godavari Drugs is trading -1.54% lower at Rs 115.20 as compared to its last closing price. Godavari Drugs has been trading in the price range of 119.00 & 115.20. Godavari Drugs has given 52.28% in this year & -7.26% in the last 5 days. Godavari Drugs has TTM P/E ratio 23.42 as compared to the sector P/E of 33.65.The company posted a net profit of 1.11 Crores in its last quarter.Listed peers of Godavari Drugs include Sun Pharmaceutical Industries (-0.82%), Divi's Laboratories (0.06%), Torrent Pharmaceuticals (-1.25%).The Mutual Fund holding in Godavari Drugs was at 1.26% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Godavari Drugs was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 07 Oct 2026, 12:03 PM IST
- BetaLow volatility0.67Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry1.08The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values1.56The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values23.05Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation10.77The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Godavari Drugs Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,786.20 | -0.82 | 4,28,559.11 | 38.87 | 5.62 | 0.82 | 0.47 |
| Divi's Laboratories | 9,550.80 | 0.06 | 2,53,543.73 | 74.03 | 11.59 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,718.25 | -1.25 | 1,79,460.64 | 76.43 | 20.2 | 0.76 | 141.16 |
| Cipla | 1,329.00 | -1.04 | 1,07,364.38 | 28.01 | 3.38 | 0.90 | 1.11 |
| Zydus Lifesciences | 1,156.65 | -0.29 | 1,15,376.28 | 21.29 | 4.26 | 0.09 | 14.22 |
Godavari Drugs Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-27 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2026-01-15 | Preferential issue of shares |
| 2025-11-14 | Quarterly Results |
About the company Godavari Drugs
- IndustryBiotechnology & Drugs
- ISININE362C01012
- BSE Code530317
- NSE Code
Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and its intermediates. The Company is engaged in the business of contract manufacturing, loan license manufacturing, manufacturing and supply of API, drug intermediaries and fine chemicals. It operates through manufacture and sale of API and its intermediates segment. Its manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The Company's facility has multiple production blocks for API's, drug intermediates and fine chemicals.
Godavari Drugs Share Price FAQs
Godavari Drugs is trading at 115.20 as on Wed Oct 07 2026 04:31:42. This is -1.54% lower as compared to its previous closing price of 117.00.
The market capitalization of Godavari Drugs is 116.67 Cr as on Wed Oct 07 2026 04:31:42.
The 52 wk high for Godavari Drugs is 135.25 whereas the 52 wk low is 69.70
Godavari Drugs can be analyzed on the following key metrics -
- TTM P/E: 23.42
- Sector P/E: 33.65
- Dividend Yield: 0.00%
- D/E ratio: -
Godavari Drugs reported a net profit of 4.09 Cr in 2026.
The Mutual Fund Shareholding was 1.26% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Godavari Drugs QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.